BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan X, Jin WY, Lu J, Wang J, Wang YT. Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation. Nat Neurosci 2014;17:471-80. [PMID: 24464042 DOI: 10.1038/nn.3637] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Ma S, Ji J, Tong Y, Zhu Y, Dou J, Zhang X, Xu S, Zhu T, Xu X, You Q, Jiang Z. Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gross GG, Straub C, Perez-Sanchez J, Dempsey WP, Junge JA, Roberts RW, Trinh le A, Fraser SE, De Koninck Y, De Koninck P, Sabatini BL, Arnold DB. An E3-ligase-based method for ablating inhibitory synapses. Nat Methods 2016;13:673-8. [PMID: 27271196 DOI: 10.1038/nmeth.3894] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
3 Lopez‐barbosa N, Ludwicki MB, Delisa MP. Proteome editing using engineered proteins that hijack cellular quality control machinery. AIChE J 2020;66. [DOI: 10.1002/aic.16854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Li W, Dou J, Yang J, Xu H, She H. Targeting Chaperone-Mediated Autophagy for Disease Therapy. Curr Pharmacol Rep 2018;4:261-75. [PMID: 34540559 DOI: 10.1007/s40495-018-0138-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Meloni BP, Milani D, Edwards AB, Anderton RS, O'Hare Doig RL, Fitzgerald M, Palmer TN, Knuckey NW. Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties. Pharmacol Ther 2015;153:36-54. [PMID: 26048328 DOI: 10.1016/j.pharmthera.2015.06.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
6 Pei J, Wang G, Feng L, Zhang J, Jiang T, Sun Q, Ouyang L. Targeting Lysosomal Degradation Pathways: New Strategies and Techniques for Drug Discovery. J Med Chem 2021;64:3493-507. [PMID: 33764774 DOI: 10.1021/acs.jmedchem.0c01689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dosch R. Next generation mothers: Maternal control of germline development in zebrafish. Critical Reviews in Biochemistry and Molecular Biology 2014;50:54-68. [DOI: 10.3109/10409238.2014.985816] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
8 Banik SM, Pedram K, Wisnovsky S, Ahn G, Riley NM, Bertozzi CR. Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature 2020;584:291-7. [PMID: 32728216 DOI: 10.1038/s41586-020-2545-9] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 42.5] [Reference Citation Analysis]
9 Xu J, Brosseau JP, Shi H. Targeted degradation of immune checkpoint proteins: emerging strategies for cancer immunotherapy. Oncogene 2020;39:7106-13. [PMID: 33024277 DOI: 10.1038/s41388-020-01491-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Bondeson DP, Crews CM. Targeted Protein Degradation by Small Molecules. Annu Rev Pharmacol Toxicol 2017;57:107-23. [PMID: 27732798 DOI: 10.1146/annurev-pharmtox-010715-103507] [Cited by in Crossref: 90] [Cited by in F6Publishing: 82] [Article Influence: 15.0] [Reference Citation Analysis]
11 Gu X, Han M, Du Y, Wu Y, Xu Y, Zhou X, Ye D, Wang HL. Pb disrupts autophagic flux through inhibiting the formation and activity of lysosomes in neural cells. Toxicol In Vitro 2019;55:43-50. [PMID: 30496793 DOI: 10.1016/j.tiv.2018.11.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
12 Zhong Y, Chi F, Wu H, Liu Y, Xie Z, Huang W, Shi W, Qian H. Emerging targeted protein degradation tools for innovative drug discovery: From classical PROTACs to the novel and beyond. European Journal of Medicinal Chemistry 2022;231:114142. [DOI: 10.1016/j.ejmech.2022.114142] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
13 Deng S, Zhou X, Xu J. Checkpoints Under Traffic Control: From and to Organelles. In: Xu J, editor. Regulation of Cancer Immune Checkpoints. Singapore: Springer; 2020. pp. 431-53. [DOI: 10.1007/978-981-15-3266-5_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Walker Z, Possin KL, Boeve BF, Aarsland D. Lewy body dementias. Lancet 2015;386:1683-97. [PMID: 26595642 DOI: 10.1016/S0140-6736(15)00462-6] [Cited by in Crossref: 268] [Cited by in F6Publishing: 92] [Article Influence: 44.7] [Reference Citation Analysis]
15 Potjewyd FM, Axtman AD. Exploration of Aberrant E3 Ligases Implicated in Alzheimer's Disease and Development of Chemical Tools to Modulate Their Function. Front Cell Neurosci 2021;15:768655. [PMID: 34867205 DOI: 10.3389/fncel.2021.768655] [Reference Citation Analysis]
16 Nowosad A, Besson A. Lysosomes at the Crossroads of Cell Metabolism, Cell Cycle, and Stemness. Int J Mol Sci 2022;23:2290. [PMID: 35216401 DOI: 10.3390/ijms23042290] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zuo W, Zhao J, Zhang J, Fang Z, Deng J, Fan Z, Guo Y, Han J, Hou W, Dong H, Xu F, Xiong L. MD2 contributes to the pathogenesis of perioperative neurocognitive disorder via the regulation of α5GABAA receptors in aged mice. J Neuroinflammation 2021;18:204. [PMID: 34530841 DOI: 10.1186/s12974-021-02246-4] [Reference Citation Analysis]
18 Gao SQ, Zhang H, He JG, Zheng HL, Zhang PW, Xu JF, Shen ZC, Zhao HH, Wang F, Hu ZL, Chen JG. Neuronal HMGB1 in nucleus accumbens regulates cocaine reward memory. Addict Biol 2020;25:e12739. [PMID: 31056833 DOI: 10.1111/adb.12739] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Zhao L, Zhao J, Zhong K, Tong A, Jia D. Targeted protein degradation: mechanisms, strategies and application. Sig Transduct Target Ther 2022;7. [DOI: 10.1038/s41392-022-00966-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
20 Schmidt ME, Caron NS, Aly AE, Lemarié FL, Dal Cengio L, Ko Y, Lazic N, Anderson L, Nguyen B, Raymond LA, Hayden MR. DAPK1 Promotes Extrasynaptic GluN2B Phosphorylation and Striatal Spine Instability in the YAC128 Mouse Model of Huntington Disease. Front Cell Neurosci 2020;14:590569. [PMID: 33250715 DOI: 10.3389/fncel.2020.590569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Oláh J, Szénási T, Lehotzky A, Norris V, Ovádi J. Challenges in Discovering Drugs That Target the Protein-Protein Interactions of Disordered Proteins. Int J Mol Sci 2022;23:1550. [PMID: 35163473 DOI: 10.3390/ijms23031550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Kumar D, Hassan MI. Targeted protein degraders march towards the clinic for neurodegenerative diseases. Ageing Res Rev 2022;78:101616. [PMID: 35378298 DOI: 10.1016/j.arr.2022.101616] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Bianco A, Muller S. Nanomaterials, Autophagy, and Lupus Disease. ChemMedChem 2016;11:166-74. [PMID: 26194870 DOI: 10.1002/cmdc.201500233] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
24 Yin A, Guo H, Tao L, Cai G, Wang Y, Yao L, Xiong L, Zhang J, Li Y. NDRG2 Protects the Brain from Excitotoxicity by Facilitating Interstitial Glutamate Uptake. Transl Stroke Res 2020;11:214-27. [PMID: 31250377 DOI: 10.1007/s12975-019-00708-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
25 Sahoo S, Padhy AA, Kumari V, Mishra P. Role of Ubiquitin-Proteasome and Autophagy-Lysosome Pathways in α-Synuclein Aggregate Clearance. Mol Neurobiol 2022. [PMID: 35699874 DOI: 10.1007/s12035-022-02897-1] [Reference Citation Analysis]
26 Wang Y, Deng S, Xu J. Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets. Cancer Biol Med 2020;17:583-98. [PMID: 32944392 DOI: 10.20892/j.issn.2095-3941.2020.0066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zou Y, Ma D, Wang Y. The PROTAC technology in drug development. Cell Biochem Funct 2019;37:21-30. [PMID: 30604499 DOI: 10.1002/cbf.3369] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 23.3] [Reference Citation Analysis]
28 Ge Y, Chen W, Axerio-Cilies P, Wang YT. NMDARs in Cell Survival and Death: Implications in Stroke Pathogenesis and Treatment. Trends Mol Med 2020;26:533-51. [PMID: 32470382 DOI: 10.1016/j.molmed.2020.03.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
29 Whitmarsh-Everiss T, Laraia L. Small molecule probes for targeting autophagy. Nat Chem Biol 2021;17:653-64. [PMID: 34035513 DOI: 10.1038/s41589-021-00768-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
30 Li V, Wang YT. Molecular mechanisms of NMDA receptor-mediated excitotoxicity: implications for neuroprotective therapeutics for stroke. Neural Regen Res 2016;11:1752-3. [PMID: 28123410 DOI: 10.4103/1673-5374.194713] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
31 Chu T, Gao N, Li Q, Chen P, Yang X, Chen Y, Zhao Y, Li Y. Specific Knockdown of Endogenous Tau Protein by Peptide-Directed Ubiquitin-Proteasome Degradation. Cell Chemical Biology 2016;23:453-61. [DOI: 10.1016/j.chembiol.2016.02.016] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 12.0] [Reference Citation Analysis]
32 Delport A, Hewer R. Inducing the Degradation of Disease-Related Proteins Using Heterobifunctional Molecules. Molecules 2019;24:E3272. [PMID: 31500395 DOI: 10.3390/molecules24183272] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
33 Hyun S, Shin D. Chemical-Mediated Targeted Protein Degradation in Neurodegenerative Diseases. Life (Basel) 2021;11:607. [PMID: 34202541 DOI: 10.3390/life11070607] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Verma R, Mohl D, Deshaies RJ. Harnessing the Power of Proteolysis for Targeted Protein Inactivation. Mol Cell 2020;77:446-60. [PMID: 32004468 DOI: 10.1016/j.molcel.2020.01.010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 33.0] [Reference Citation Analysis]
35 Long Y, Cheng Y, Yang J, Yang T, Lai Y. Abeta-induced presynaptic release of UBC9 through extracellular vesicles involves SNAP23. Neuroscience Letters 2022;785:136771. [DOI: 10.1016/j.neulet.2022.136771] [Reference Citation Analysis]
36 Velayudhan L, Ffytche D, Ballard C, Aarsland D. New Therapeutic Strategies for Lewy Body Dementias. Curr Neurol Neurosci Rep 2017;17:68. [PMID: 28741230 DOI: 10.1007/s11910-017-0778-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
37 Sharma N, Kaur R, Yadav B, Shah K, Pandey H, Choudhary D, Jain P, Aggarwal A, Vinson C, Rishi V. Transient Delivery of A-C/EBP Protein Perturbs Differentiation of 3T3-L1 Cells and Induces Preadipocyte Marker Genes. Front Mol Biosci 2020;7:603168. [PMID: 33569390 DOI: 10.3389/fmolb.2020.603168] [Reference Citation Analysis]
38 Jin JW, Fan X, Del Cid-Pellitero E, Liu XX, Zhou L, Dai C, Gibbs E, He W, Li H, Wu X, Hill A, Leavitt BR, Cashman N, Liu L, Lu J, Durcan TM, Dong Z, Fon EA, Wang YT. Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson's disease models. Commun Biol 2021;4:232. [PMID: 33608634 DOI: 10.1038/s42003-021-01746-6] [Reference Citation Analysis]
39 Rakhit R, Navarro R, Wandless TJ. Chemical biology strategies for posttranslational control of protein function. Chem Biol 2014;21:1238-52. [PMID: 25237866 DOI: 10.1016/j.chembiol.2014.08.011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
40 Au YZ, Wang T, Sigua LH, Qi J. Peptide-Based PROTAC: The Predator of Pathological Proteins. Cell Chem Biol 2020;27:637-9. [PMID: 32559499 DOI: 10.1016/j.chembiol.2020.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 Regan L, Hinrichsen MR, Oi C. Protein engineering strategies with potential applications for altering clinically relevant cellular pathways at the protein level. Expert Rev Proteomics 2016;13:481-93. [PMID: 27031866 DOI: 10.1586/14789450.2016.1172966] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
42 Pan C, Yang H, Lu Y, Hu S, Wu Y, He Q, Dong X. Recent advance of peptide-based molecules and nonpeptidic small-molecules modulating PD-1/PD-L1 protein-protein interaction or targeting PD-L1 protein degradation. Eur J Med Chem 2021;213:113170. [PMID: 33454550 DOI: 10.1016/j.ejmech.2021.113170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
43 Wang F, Muller S. Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target. Front Immunol 2015;6:252. [PMID: 26042127 DOI: 10.3389/fimmu.2015.00252] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
44 Zhang Y, Han L, Tian X, Peng C, Chen Y. Ligand‐Directed Caging Enables the Control of Endogenous DNA Alkyltransferase Activity with Light inside Live Cells. Angewandte Chemie. [DOI: 10.1002/ange.202115472] [Reference Citation Analysis]
45 Meloni BP, Mastaglia FL, Knuckey NW. Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action. Front Neurol 2020;11:108. [PMID: 32158425 DOI: 10.3389/fneur.2020.00108] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
46 Pei J, Pan X, Wang A, Shuai W, Bu F, Tang P, Zhang S, Zhang Y, Wang G, Ouyang L. Developing potent LC3-targeting AUTAC tools for protein degradation with selective autophagy. Chem Commun (Camb) 2021;57:13194-7. [PMID: 34816823 DOI: 10.1039/d1cc04661f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Fang Z, Wu D, Deng J, Yang Q, Zhang X, Chen J, Wang S, Hu S, Hou W, Ning S, Ding Y, Fan Z, Jiang Z, Kang J, Liu Y, Miao J, Ji X, Dong H, Xiong L. An MD2-perturbing peptide has therapeutic effects in rodent and rhesus monkey models of stroke. Sci Transl Med 2021;13:eabb6716. [PMID: 34108252 DOI: 10.1126/scitranslmed.abb6716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
48 Zhang H, Duan C, Yang H. Defective autophagy in Parkinson's disease: lessons from genetics. Mol Neurobiol 2015;51:89-104. [PMID: 24990317 DOI: 10.1007/s12035-014-8787-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
49 Wang H, Ma JL, Yang YG, Song Y, Wu J, Qin YY, Zhao XL, Wang J, Zou LL, Wu JF, Li JM, Liu CB. Efficient therapeutic delivery by a novel cell-permeant peptide derived from KDM4A protein for antitumor and antifibrosis. Oncotarget 2016;7:49075-90. [PMID: 27081693 DOI: 10.18632/oncotarget.8682] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
50 Burslem GM, Crews CM. Small-Molecule Modulation of Protein Homeostasis. Chem Rev 2017;117:11269-301. [DOI: 10.1021/acs.chemrev.7b00077] [Cited by in Crossref: 120] [Cited by in F6Publishing: 103] [Article Influence: 24.0] [Reference Citation Analysis]
51 Clift D, So C, Mcewan WA, James LC, Schuh M. Acute and rapid degradation of endogenous proteins by Trim-Away. Nat Protoc 2018;13:2149-75. [DOI: 10.1038/s41596-018-0028-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 10.5] [Reference Citation Analysis]
52 Fan X, Wang YT. SNIPER peptide-mediated degradation of endogenous proteins. Curr Protoc Chem Biol 2015;7:1-16. [PMID: 25727059 DOI: 10.1002/9780470559277.ch140202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Gao N, Chen YX, Zhao YF, Li YM. Chemical Methods to Knock Down the Amyloid Proteins. Molecules 2017;22:E916. [PMID: 28587164 DOI: 10.3390/molecules22060916] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
54 Pastrana E. Knocking down Goliath. Nat Methods 2014;11:232. [PMID: 24724170 DOI: 10.1038/nmeth.2875] [Reference Citation Analysis]
55 Tomoshige S, Ishikawa M. PROTACs and Other Chemical Protein Degradation Technologies for the Treatment of Neurodegenerative Disorders. Angew Chem Int Ed Engl 2021;60:3346-54. [PMID: 32410219 DOI: 10.1002/anie.202004746] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
56 Fan X, Jin WY, Wang YT. The NMDA receptor complex: a multifunctional machine at the glutamatergic synapse. Front Cell Neurosci 2014;8:160. [PMID: 24959120 DOI: 10.3389/fncel.2014.00160] [Cited by in Crossref: 43] [Cited by in F6Publishing: 50] [Article Influence: 5.4] [Reference Citation Analysis]
57 Wu T, Yoon H, Xiong Y, Dixon-Clarke SE, Nowak RP, Fischer ES. Targeted protein degradation as a powerful research tool in basic biology and drug target discovery. Nat Struct Mol Biol 2020;27:605-14. [PMID: 32541897 DOI: 10.1038/s41594-020-0438-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 15.0] [Reference Citation Analysis]
58 Maneiro M, De Vita E, Conole D, Kounde CS, Zhang Q, Tate EW. PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugs. Prog Med Chem 2021;60:67-190. [PMID: 34147206 DOI: 10.1016/bs.pmch.2021.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Chen D, Zhou XZ, Lee TH. Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer's Disease. Recent Pat Anticancer Drug Discov 2019;14:144-57. [PMID: 30569876 DOI: 10.2174/1574892814666181218170257] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
60 Ma M, Xiong W, Hu F, Deng MF, Huang X, Chen JG, Man HY, Lu Y, Liu D, Zhu LQ. A novel pathway regulates social hierarchy via lncRNA AtLAS and postsynaptic synapsin IIb. Cell Res 2020;30:105-18. [PMID: 31959917 DOI: 10.1038/s41422-020-0273-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
61 Kim N, Chen D, Zhou XZ, Lee TH. Death-Associated Protein Kinase 1 Phosphorylation in Neuronal Cell Death and Neurodegenerative Disease. Int J Mol Sci 2019;20:E3131. [PMID: 31248062 DOI: 10.3390/ijms20133131] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
62 Wu Y, Yang X, Yao Z, Dong X, Zhang D, Hu Y, Zhang S, Lin J, Chen J, An S, Ye H, Zhang S, Qiu Z, He Z, Huang M, Wei G, Zhu X. C19orf66 interrupts Zika virus replication by inducing lysosomal degradation of viral NS3. PLoS Negl Trop Dis 2020;14:e0008083. [PMID: 32150556 DOI: 10.1371/journal.pntd.0008083] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
63 Qu J, Ren X, Xue F, He Y, Zhang R, Zheng Y, Huang H, Wang W, Zhang J. Specific Knockdown of α-Synuclein by Peptide-Directed Proteasome Degradation Rescued Its Associated Neurotoxicity. Cell Chemical Biology 2020;27:751-762.e4. [DOI: 10.1016/j.chembiol.2020.03.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
64 Ottis P, Crews CM. Proteolysis-Targeting Chimeras: Induced Protein Degradation as a Therapeutic Strategy. ACS Chem Biol 2017;12:892-8. [PMID: 28263557 DOI: 10.1021/acschembio.6b01068] [Cited by in Crossref: 131] [Cited by in F6Publishing: 127] [Article Influence: 26.2] [Reference Citation Analysis]
65 Wang H, Yao H, Li C, Shi H, Lan J, Li Z, Zhang Y, Liang L, Fang JY, Xu J. HIP1R targets PD-L1 to lysosomal degradation to alter T cell-mediated cytotoxicity. Nat Chem Biol 2019;15:42-50. [PMID: 30397328 DOI: 10.1038/s41589-018-0161-x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 16.8] [Reference Citation Analysis]
66 Girling KD, Demers M, Laine J, Zhang S, Wang YT, Graham RK. Activation of caspase-6 and cleavage of caspase-6 substrates is an early event in NMDA receptor-mediated excitotoxicity. Journal of Neuroscience Research 2018;96:391-406. [DOI: 10.1002/jnr.24153] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
67 Rambacher KM, Calabrese MF, Yamaguchi M. Perspectives on the development of first-in-class protein degraders. Future Med Chem 2021;13:1203-26. [PMID: 34015962 DOI: 10.4155/fmc-2021-0033] [Reference Citation Analysis]
68 Dou J, Su P, Xu C, Wen Z, Mao Z, Li W. Targeting Hsc70-based autophagy to eliminate amyloid β oligomers. Biochem Biophys Res Commun 2020;524:923-8. [PMID: 32057360 DOI: 10.1016/j.bbrc.2020.02.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
69 Ghosh R, Vinod V, Symons JD, Boudina S. Protein and Mitochondria Quality Control Mechanisms and Cardiac Aging. Cells 2020;9:E933. [PMID: 32290135 DOI: 10.3390/cells9040933] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
70 Valeur E, Narjes F, Ottmann C, Plowright AT. Emerging modes-of-action in drug discovery. Medchemcomm 2019;10:1550-68. [PMID: 31673315 DOI: 10.1039/c9md00263d] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
71 Li Y, Yin A, Sun X, Zhang M, Zhang J, Wang P, Xie R, Li W, Fan Z, Zhu Y, Wang H, Dong H, Wu S, Xiong L. Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior. J Clin Invest 2017;127:4270-84. [PMID: 29058689 DOI: 10.1172/JCI94455] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 4.6] [Reference Citation Analysis]
72 Kalia LV, Kalia SK, Lang AE. Disease-modifying strategies for Parkinson's disease. Mov Disord 2015;30:1442-50. [PMID: 26208210 DOI: 10.1002/mds.26354] [Cited by in Crossref: 129] [Cited by in F6Publishing: 118] [Article Influence: 18.4] [Reference Citation Analysis]
73 Jin Y, Lu M, Wang Y, Shan W, Wang X, You Q, Jiang Z. Azo-PROTAC: Novel Light-Controlled Small-Molecule Tool for Protein Knockdown. J Med Chem 2020;63:4644-54. [DOI: 10.1021/acs.jmedchem.9b02058] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
74 Xiong W, Wagner T, Yan L, Grillet N, Müller U. Using injectoporation to deliver genes to mechanosensory hair cells. Nat Protoc 2014;9:2438-49. [PMID: 25232939 DOI: 10.1038/nprot.2014.168] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
75 Zhou YF, Wang J, Deng MF, Chi B, Wei N, Chen JG, Liu D, Yin X, Lu Y, Zhu LQ. The Peptide-Directed Lysosomal Degradation of CDK5 Exerts Therapeutic Effects against Stroke. Aging Dis 2019;10:1140-5. [PMID: 31595208 DOI: 10.14336/AD.2018.1225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
76 Lai Y, Liu L, Hu X, He L, Chen G. Estrogen Modulates ubc9 Expression and Synaptic Redistribution in the Brain of APP/PS1 Mice and Cortical Neurons. J Mol Neurosci 2017;61:436-48. [DOI: 10.1007/s12031-017-0884-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
77 Clift D, McEwan WA, Labzin LI, Konieczny V, Mogessie B, James LC, Schuh M. A Method for the Acute and Rapid Degradation of Endogenous Proteins. Cell 2017;171:1692-1706.e18. [PMID: 29153837 DOI: 10.1016/j.cell.2017.10.033] [Cited by in Crossref: 170] [Cited by in F6Publishing: 147] [Article Influence: 34.0] [Reference Citation Analysis]